Verified Nov 2026
Batteries & E-Mobility
·
San Diego, California
·
Since 1995
Invivoscribe is a biotechnology company headquartered in San Diego, California, founded in 1995. It employs an estimated 200 to 500 people and has an estimated annual revenue of $10 to $50 million. The company develops PCR-based and NGS-based molecular diagnostic products for oncology and hematology, serving clinical laboratories, pharmaceutical companies, and healthcare providers. In 2026 it began commercial shipments of its PrepQuant system for high-sensitivity sample preparation in minimal residual disease testing.
Invivoscribe at a glance
Revenue
$10-50M
Est. band
Employees
200-500
Founded
1995
Headquarters
San Diego, California
Certifications
ISO 13485
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
STABILITY SIGNALS
Established & active
31 years in operation (founded 1995).
Holds ISO 13485 certification(s) per public sources.
Overview
Invivoscribe is a biotechnology company headquartered in San Diego, California, founded in 1995. It employs an estimated 200 to 500 people and has an estimated annual revenue of $10 to $50 million. The company develops PCR-based and NGS-based molecular diagnostic products for oncology and hematology, serving clinical laboratories, pharmaceutical companies, and healthcare providers. In 2026 it began commercial shipments of its PrepQuant system for high-sensitivity sample preparation in minimal residual disease testing.
At a glance
Attribute | Detail |
|---|---|
Founded | 1995 |
Headquarters | San Diego, California |
Employees | 200-500 |
Revenue | $10-50M (estimated) |
Primary capability | Batteries & E-Mobility |
Certifications | ISO 13485 |
What Invivoscribe makes
The company offers the IdentiClone and LymphoTrack product lines for clonality and minimal residual disease testing, and its IdentiClone Dx IGH assay has received IVDR certification.
Certifications
Invivoscribe is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — invivoscribe.com
Latest developments
2026-10-06 — Invivoscribe Advances Molecular Clonality Testing Portfolio with a Comprehensive LymphoTrack® Flex Suite - Invivoscribe (invivoscribe.com)
2026-09-02 — Invivoscribe Begins Commercial Shipments of PrepQuantTM Systems, Enabling High-Sensitivity Sample Preparation for MRD Testing - Invivoscribe (invivoscribe.com)
2026-08-04 — LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care - Invivoscribe (invivoscribe.com)
2026-04-15 — PrepQuant™ System Launch | Sample Preparation | Invivoscribe (invivoscribe.com)
2026-03-26 — Invivoscribe Expands IVDR Portfolio with IdentiClone Dx IGH Assay Certification - Invivoscribe (invivoscribe.com)
2025-10-09 — Newmark Arranges Lease Renewal for Invivoscribe’s U.S.… | Newmark (nmrk.com)
Company details
Invivoscribe is privately held, and its serviced industries include medical diagnostics, with clinical testing delivered through accredited subsidiary laboratories. Invivoscribe was founded in 1995, has an estimated 200-500 employees, and is headquartered in San Diego, California. On the LightSource stability read it is rated "Established & active": 31 years in operation (founded 1995). Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does Invivoscribe make?
Invivoscribe is a biotechnology company headquartered in San Diego, California, founded in 1995. It employs an estimated 200 to 500 people and has an estimated annual revenue of $10 to $50 million. The company develops PCR-based and NGS-based molecular diagnostic products for oncology and hematology, serving clinical laboratories, pharmaceutical companies, and healthcare providers. In 2026 it began commercial shipments of its PrepQuant system for high-sensitivity sample preparation in minimal residual disease testing.
Where is Invivoscribe headquartered?
Invivoscribe is headquartered in San Diego, California (10222 Barnes Canyon Rd, San Diego, California, 92121-2710).
When was Invivoscribe founded?
Invivoscribe was founded in 1995.
How big is Invivoscribe?
Invivoscribe has an estimated 200-500 employees, with revenue in the $10-50M range (estimated).
What certifications does Invivoscribe hold?
Invivoscribe lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.